Publication | Closed Access

Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).

Molecular PharmacologyPharmacological StudyMedicinePhysiologyPharmacological AgentExperimental PharmacologyPharmacotherapyBay K 5552PharmacologyDrug DiscoveryIsobutyl Methyl